May S, Giordano T, Gottlieb A
JMIR Form Res. 2021; 5(11):e28620.
PMID: 34842532
PMC: 8727048.
DOI: 10.2196/28620.
Chhatre S, Schapira M, Metzger D, Jayadevappa R
EClinicalMedicine. 2020; 17:100205.
PMID: 31891138
PMC: 6933147.
DOI: 10.1016/j.eclinm.2019.11.001.
Arens Y, Gaisa M, Goldstone S, Liu Y, Wisnivesky J, Sigel C
Dis Colon Rectum. 2019; 62(8):934-940.
PMID: 30888979
PMC: 6613994.
DOI: 10.1097/DCR.0000000000001384.
Buckstein M, Arens Y, Wisnivesky J, Gaisa M, Goldstone S, Sigel K
Dis Colon Rectum. 2018; 61(7):787-794.
PMID: 29771796
PMC: 5992075.
DOI: 10.1097/DCR.0000000000001103.
Paul D, Neely N, Clement M, Riley I, Al-Hegelan M, Phelan M
J Am Med Inform Assoc. 2017; 25(2):150-157.
PMID: 28645207
PMC: 6381767.
DOI: 10.1093/jamia/ocx061.
Development of an electronic medical record-based algorithm to identify patients with unknown HIV status.
Felsen U, Bellin E, Cunningham C, Zingman B
AIDS Care. 2014; 26(10):1318-25.
PMID: 24779521
PMC: 4095997.
DOI: 10.1080/09540121.2014.911813.
Prognosis in HIV-infected patients with non-small cell lung cancer.
Sigel K, Crothers K, Dubrow R, Krauskopf K, Jao J, Sigel C
Br J Cancer. 2013; 109(7):1974-80.
PMID: 24022194
PMC: 3790190.
DOI: 10.1038/bjc.2013.545.
The cost and incidence of prescribing errors among privately insured HIV patients.
Hellinger F, Encinosa W
Pharmacoeconomics. 2009; 28(1):23-34.
PMID: 20014874
DOI: 10.2165/11313810-000000000-00000.
Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.
Bedimo R, McGinnis K, Dunlap M, Rodriguez-Barradas M, Justice A
J Acquir Immune Defic Syndr. 2009; 52(2):203-8.
PMID: 19617846
PMC: 2814969.
DOI: 10.1097/QAI.0b013e3181b033ab.
Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity?.
Goulet J, Fultz S, Rimland D, Butt A, Gibert C, Rodriguez-Barradas M
Clin Infect Dis. 2008; 45(12):1593-601.
PMID: 18190322
PMC: 3687553.
DOI: 10.1086/523577.
Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.
Braithwaite R, Kozal M, Chang C, Roberts M, Fultz S, Goetz M
AIDS. 2007; 21(12):1579-89.
PMID: 17630553
PMC: 3460378.
DOI: 10.1097/QAD.0b013e3281532b31.
Antiretroviral therapy and health care utilization: a study of privately insured men and women with HIV disease.
Hellinger F, Encinosa W
Health Serv Res. 2004; 39(4 Pt 1):949-67.
PMID: 15230936
PMC: 1361046.
DOI: 10.1111/j.1475-6773.2004.00266.x.
Understanding racial disparities in HIV using data from the veterans aging cohort 3-site study and VA administrative data.
McGinnis K, Fine M, Sharma R, Skanderson M, Wagner J, Rodriguez-Barradas M
Am J Public Health. 2003; 93(10):1728-33.
PMID: 14534229
PMC: 1448041.
DOI: 10.2105/ajph.93.10.1728.
Initiation and continuation of newer antiretroviral treatments among medicaid recipients with AIDS.
Crystal S, Sambamoorthi U, Moynihan P, McSpiritt E
J Gen Intern Med. 2002; 16(12):850-9.
PMID: 11903765
PMC: 1495297.
Use of protease inhibitors and non-nucleoside reverse transcriptase inhibitors among Medicaid beneficiaries with AIDS.
Sambamoorthi U, Moynihan P, McSpiritt E, Crystal S
Am J Public Health. 2001; 91(9):1474-81.
PMID: 11527784
PMC: 1446807.
DOI: 10.2105/ajph.91.9.1474.